Nian Lu

1.1k total citations
33 papers, 296 citations indexed

About

Nian Lu is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Nian Lu has authored 33 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Otorhinolaryngology and 11 papers in Surgery. Recurrent topics in Nian Lu's work include Head and Neck Cancer Studies (17 papers), Radiomics and Machine Learning in Medical Imaging (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Nian Lu is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Radiomics and Machine Learning in Medical Imaging (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Nian Lu collaborates with scholars based in China, United States and Hong Kong. Nian Lu's co-authors include Yan‐Qun Xiang, Chuanmiao Xie, Wei‐Xiong Xia, Wang‐Zhong Li, Guoying Liu, Hu L, Weijing Zhang, Shu‐Hui Lv, Shaohan Yin and Zhaoxiang Ye and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Nian Lu

31 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nian Lu China 10 145 130 84 80 64 33 296
Chaosu Hu China 8 54 0.4× 90 0.7× 87 1.0× 125 1.6× 71 1.1× 47 261
Gokoulakrichenane Loganadane France 10 147 1.0× 126 1.0× 164 2.0× 101 1.3× 76 1.2× 39 374
Hongyu Zhou China 11 82 0.6× 90 0.7× 61 0.7× 29 0.4× 56 0.9× 32 402
Hai‐Qiang Mai China 11 58 0.4× 135 1.0× 87 1.0× 176 2.2× 82 1.3× 23 293
Zhi-Mei Huang China 9 63 0.4× 124 1.0× 97 1.2× 34 0.4× 76 1.2× 12 324
Anussara Prayongrat Thailand 11 81 0.6× 88 0.7× 131 1.6× 119 1.5× 93 1.5× 43 298
Tommaso Carfagno Italy 10 158 1.1× 90 0.7× 88 1.0× 21 0.3× 44 0.7× 16 260
Valentina Vanoni Italy 12 100 0.7× 98 0.8× 97 1.2× 73 0.9× 102 1.6× 21 332
Oyeon Cho South Korea 12 53 0.4× 202 1.6× 96 1.1× 42 0.5× 107 1.7× 28 378
François‐Xavier Hanin Belgium 13 290 2.0× 103 0.8× 234 2.8× 157 2.0× 93 1.5× 21 554

Countries citing papers authored by Nian Lu

Since Specialization
Citations

This map shows the geographic impact of Nian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nian Lu more than expected).

Fields of papers citing papers by Nian Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nian Lu. The network helps show where Nian Lu may publish in the future.

Co-authorship network of co-authors of Nian Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Nian Lu. A scholar is included among the top collaborators of Nian Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nian Lu. Nian Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Li, Han, Run Lin, Yanna Zhang, et al.. (2024). N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation. Molecular Cancer. 23(1). 5–5. 22 indexed citations
4.
Chen, Chun, Guoying Liu, Ting Fang, et al.. (2024). Combination strategy exploration for prior treated recurrent or metastatic nasopharyngeal carcinoma in the era of immunotherapy. Scientific Reports. 14(1). 1768–1768. 2 indexed citations
5.
6.
7.
Liu, Guoying, Lin Wang, Jianwei Wang, et al.. (2024). Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial. Nature Communications. 15(1). 1029–1029. 9 indexed citations
8.
Fang, Ting, et al.. (2023). Anti-PD1 rechallenge in combination with anti-angiogenesis or anti-EGFR treatment beyond progression in recurrent/metastatic nasopharyngeal carcinoma patients. Critical Reviews in Oncology/Hematology. 190. 104113–104113. 8 indexed citations
9.
Lin, Chao, Nian Lu, Jia Guo, et al.. (2023). Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma. Radiotherapy and Oncology. 186. 109802–109802. 5 indexed citations
10.
Li, Wang‐Zhong, Shu‐Hui Lv, Guoying Liu, et al.. (2023). Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma. Frontiers in Immunology. 14. 1124066–1124066.
11.
Liu, Guoying, Nian Lu, Wang‐Zhong Li, et al.. (2023). Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor. Frontiers in Immunology. 14. 1069010–1069010. 3 indexed citations
12.
13.
14.
Liu, Guoying, Wei‐Xiong Xia, Zhuofei Bi, et al.. (2022). Plasma Circulating Tumor Epstein–Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal Carcinoma. Frontiers in Oncology. 12. 860700–860700. 1 indexed citations
15.
Liu, Ying, Minghao Wu, Yuwei Zhang, et al.. (2021). Imaging Biomarkers to Predict and Evaluate the Effectiveness of Immunotherapy in Advanced Non-Small-Cell Lung Cancer. Frontiers in Oncology. 11. 657615–657615. 51 indexed citations
16.
Li, Wang‐Zhong, Xin Hua, Shu‐Hui Lv, et al.. (2021). A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma. Journal of Inflammation Research. Volume 14. 817–828. 14 indexed citations
17.
18.
Li, Philip S., Nian Lu, Richard Lee, et al.. (2014). [Long-term benefit of male circumcision to the reduction of urinary tract infections and genitourinary cancers in China].. PubMed. 20(11). 969–77. 1 indexed citations
19.
Lu, Nian, et al.. (2000). Inhibitory effects of human seminal plasma on an ELISA used to detect anti-sperm antibodies: Implications for the determination of sperm quality. Journal of Reproductive Immunology. 47(1). 33–40. 6 indexed citations
20.
Lu, Nian. (1994). A Speculative View of Immune Recognition. Immunological Investigations. 23(1). 53–71. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaosu Hu Breakdown of academic impact, for papers by Gokoulakrichenane Loganadane Breakdown of academic impact, for papers by Hongyu Zhou Breakdown of academic impact, for papers by Hai‐Qiang Mai Breakdown of academic impact, for papers by Zhi-Mei Huang Breakdown of academic impact, for papers by Anussara Prayongrat Breakdown of academic impact, for papers by Tommaso Carfagno Breakdown of academic impact, for papers by Valentina Vanoni Breakdown of academic impact, for papers by Oyeon Cho Breakdown of academic impact, for papers by François‐Xavier Hanin
Rankless by CCL
2026